View Older Stories View More Recent Stories

Apr 21, 2014 09:15AM Roth Capital Starts Applied Genetic Tech (AGTC) at Buy; Catalysts in 2015 Add Appeal

Apr 17, 2014 10:19AM Roth Affirms Clean Diesel (CDTI) at 'Buy'; Sees L-T, Catalyst-Focused Strategy Playing Out

Apr 16, 2014 08:55AM xG Technology (XGTI) Prices 5.27M Common Offering at $1.90/Share

Apr 14, 2014 03:00PM Low European Exposure Boosts JA Solar (JASO) in Q1 - Analyst

Apr 14, 2014 01:34PM Roth Affirms Bullish Position on Retrophin (RTRX) Following Financial, Pipeline Updates

Apr 14, 2014 08:11AM Roth Capital Starts AcelRx Pharmaceuticals (ACRX) at Buy

Apr 14, 2014 06:52AM Roth Capital Upgrades PriceSmart (PSMT) to Buy

Apr 14, 2014 06:39AM Trina Solar (TSL) Follows Suit in Q1 as Europe Lowers Floor Price; Roth Maintains at 'Buy'

Apr 11, 2014 10:32AM Mixed Prelim. Q1 Numbers from Yingli Green Energy (YGE) Keep Roth at 'Neutral'

Apr 11, 2014 08:33AM NTN Buzztime (NTN) Prices 11.1M Offering at 55c/Share

Apr 11, 2014 07:59AM Roth Capital Starts Flamel Technologies (FLML) at Buy

Apr 8, 2014 02:05PM Roth Boosts PT on Sunesis Pharma (SNSS) to $15; Focus Remains on Vosaroxin

Apr 8, 2014 11:00AM PlacementTracker Publishes First Quarter 2014 PIPE Market League Tables

Apr 8, 2014 10:30AM Catalyst Pharmaceutical Partners, Inc. Announces Closing of Previously Announced Public Offering

Apr 8, 2014 09:32AM Pharmacyclics' (PCYC) IMBRUVICA Should Get Full Approval Before End of 2014; Roth Keeps at 'Buy'

Apr 7, 2014 11:57AM Streetinsider.com's Hot Lunchtime Reads 04/07: (KR) (MSFT) (SRPT) (MDVN)

Apr 7, 2014 11:14AM Pre-Clinical Data for MEI Pharma's (MEIP) Pracinostat Will Set Development Tone - Roth Capital

Apr 7, 2014 11:01AM American Apparel (APP) Price Target Reduced to $0.75 at Roth

Apr 4, 2014 12:11PM Roth Affirms Hydrogenics (HYGS) at 'Bur'; Customer-Driven Hiccup Doesn't Affect Overall Thesis

Apr 4, 2014 08:34AM Ocean Power Technologies (OPTT) Prices 3.8M Offering at $3.10/sh

Apr 4, 2014 08:30AM Ocean Power Technologies Prices Underwritten Public Offering of Common Stock

Apr 4, 2014 08:12AM Roth Capital Starts Energy Fuels (UUUU) at Buy

Apr 4, 2014 07:17AM Roth Capital Starts Uranium Resources (URRE) at Buy

Apr 3, 2014 04:39PM Ocean Power Technologies, Inc. (OPTT) Plans Common Stock Offering

Apr 3, 2014 04:29PM Ocean Power Technologies Announces Proposed Public Offering of Common Stock

Apr 3, 2014 04:01PM SolarCity (SCTY) ABS Offerings are Evolutionary Step Toward Lower-Cost Financing - Roth

Apr 3, 2014 04:01PM AGTC Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

Apr 3, 2014 09:02AM Catyalyst Pharma (CPRX) Prices 11.33M Common Offering at $2.21/Share

Apr 2, 2014 04:04PM Endocyte (ECYT) Closes 5.18M Offering; Sees Net Proceeds of $101.8M

Apr 2, 2014 04:01PM Endocyte, Inc. Closes Public Offering of Common Stock

Apr 2, 2014 08:45AM Roth Affirms Keryx (KERX) at 'Buy'; ESRD Overhang Removed

Apr 1, 2014 11:23AM Roth Lifts PT on Stemline (STML) to $62; Sees 'Pivotal' Year in 2014

Apr 1, 2014 09:50AM Roth Sees Regeneron/Sanofi Alirocumab Phase 2 Results as Positive; Maintains 'Buy' Rating (REGN)

Apr 1, 2014 08:40AM Clean Diesel (CDTI) Announces $6.9M Equity Raise

Apr 1, 2014 08:38AM CDTi to Raise Approximately $6.9 Million

Apr 1, 2014 07:47AM Roth Capital Positive on Palatin (PTN) Granting Bremelanotide Extension

Mar 31, 2014 01:59PM Roth Raises PT on Regeneron (REGN) to $382; ODYSSEY MONO, Alirocumab Data Bolsters Positive Outlook

Mar 31, 2014 01:49PM Regeneron Pharma (REGN) PT Raised to $382 at Roth Capital

Mar 31, 2014 08:39AM Roth Boosts PT on Curis (CRIS) to $10; '427 Overhang Now Lifted

Mar 28, 2014 02:05PM Notable 52-Week Highs and Lows of the Day 03/28: (AA) (ELY) (INVN) High; (EXEL) (SPEX) Low

Mar 28, 2014 11:24AM Notable Analyst Rating Changes 03/28: (SCTY) (CTSH) (INVN) Upgraded; (PNW) (CIEN) (PCG) Downgraded

Mar 28, 2014 09:22AM Cytokinetics (CYTK) Starts COSMIC-HF Phase II Enrollment; BENEFIT-ALS Still in Focus - Roth

Mar 28, 2014 07:17AM Endocyte (ECYT) Prices 4.5M Share Offering at $21

Mar 28, 2014 07:12AM Roth Capital Upgrades InvenSense (INVN) to Buy

Mar 27, 2014 06:48PM Endocyte, Inc. Prices Public Offering of Common Stock

Mar 27, 2014 10:50AM Cytokinetics' (CYTK) Initiation of CK-2127107 Phase I is Positive Development - Roth

Mar 27, 2014 10:27AM Applied Genetic Technologies (AGTC) IPO Opens Higher

Mar 27, 2014 10:21AM Alt-Energy Names Show Early Gains (FCEL)(BLDP) (PLUG)

Mar 27, 2014 10:07AM Roth Starts Active Power (ACPW) at Buy; Refocused Company Should See N-T Gains

Mar 27, 2014 08:17AM Applied Genetic Technologies (AGTC) IPO Prices at $12, Below Range

View More Recent Stories View Older Stories